Aimmune Therapeutics Inc Insider ownership
What is the Insider ownership of Aimmune Therapeutics Inc?
The Insider ownership of Aimmune Therapeutics Inc is 20.86%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NASDAQ compared to Aimmune Therapeutics Inc
Companies with insider ownership similar to Aimmune Therapeutics Inc
- Centogene N.V. Eo ,12 has Insider ownership of 20.83%
- Option Care Health has Insider ownership of 20.83%
- F&G Annuities & Life Inc has Insider ownership of 20.83%
- 56728 has Insider ownership of 20.84%
- Casa Systems Inc has Insider ownership of 20.84%
- FY (Shenzhen) Co has Insider ownership of 20.84%
- Aimmune Therapeutics Inc has Insider ownership of 20.86%
- Covenant Transportation has Insider ownership of 20.86%
- Tianli has Insider ownership of 20.87%
- Malin plc has Insider ownership of 20.87%
- MMA Capital Inc has Insider ownership of 20.88%
- Eclipse Metals has Insider ownership of 20.88%
- Nevada King Gold has Insider ownership of 20.88%